Roselabs sets up Rs 400-cr pre-filled syringe manufacturing unit

摘要

ROSELABS Bioscience Ltd and Roselabs Polymers Ltd, a part of the Roselabs Group, recently said they have invested Rs 400 crore in setting up the pre-filled syringe making facility. The company said that the World Health Organization-Good Manufacturing Practice (WHO-GMP) has granted its approval. Roselabs, which commenced production six months ago, is expecting to get regulatory approvals from 35-40 countries, mainly in the emerging markets of Latin America, South East Asia and Africa by year-end, said Zameer Agarwal, Director, Roselabs Biosciences.